Cargando…
Biologically responsive carrier-mediated anti-angiogenesis shRNA delivery for tumor treatment
Small interfering RNA (siRNA) has increased the hope for highly-efficient treatment of gene-related diseases. However, the stable and efficient delivery of therapeutic nucleic acids is a prerequisite for the successful clinical translation of RNA interfering therapy. To achieve this, we condensed th...
Autores principales: | Che, Junyi, Tao, Anqi, Chen, Shun, Li, Xiaoming, Zhao, Yi, Yuan, Weien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069559/ https://www.ncbi.nlm.nih.gov/pubmed/27759095 http://dx.doi.org/10.1038/srep35661 |
Ejemplares similares
-
Efficient and Non-Toxic Biological Response Carrier Delivering TNF-α shRNA for Gene Silencing in a Murine Model of Rheumatoid Arthritis
por: Song, Jialin, et al.
Publicado: (2016) -
Protamine nanoparticles for improving shRNA-mediated anti-cancer effects
por: Liu, Ming, et al.
Publicado: (2015) -
Lentivirus-Mediated Nox4 shRNA Invasion and Angiogenesis and Enhances Radiosensitivity in Human Glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2014) -
Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2012) -
Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy
por: Wang, Yu-Qiang, et al.
Publicado: (2013)